Although curative treatment of fibroids relies on surgical therapies, medical treatments are considered the first-line treatment to reduce the symptoms, avoid or delay surgery.
Medical therapy may also play a role as a temporizing measure for symptomatic women approaching menopause who wish to avoid surgical intervention. For women requiring surgery, medical therapy may be administered preoperatively to minimize bleeding and thereby improve preoperative hemoglobin levels, or to decrease the leiomyoma size in preparation for a minimally invasive surgical approach.
The medical management of leiomyomas should aim to improve a patient's quality of life by reducing signs and symptoms, while also minimizing side effects. However, the adverse effects associated with prolonged medical therapies limit the duration of their use. In addition, a rebound increase in the size of the leiomyomas can be observed after discontinuing hormonal medical therapy.
Every woman with fibroid doesn’t need treatment. The management of small, asymptomatic myomas is judicious observation. When the tumor is first discovered, it is appropriate to perform a pelvic ultrasound at 6-month intervals to determine the rate of growth. Medical management can be Hormonal and Non hormonal treatment depending on the symptoms and severity.